C-Reactive Protein/Albumin and Neutrophil/Albumin Ratios as Novel Inflammatory Markers in Patients with Schizophrenia
- PMID: 32894927
- PMCID: PMC7538240
- DOI: 10.30773/pi.2020.0185
C-Reactive Protein/Albumin and Neutrophil/Albumin Ratios as Novel Inflammatory Markers in Patients with Schizophrenia
Abstract
Objective: Peripheral biomarker studies in schizophrenia are insufficient to correspond to whether inflammatory markers are trait- or state-related. The main objective of this study was to compare novel biomarkers C-reactive protein/albumin ratio (CAR), neutrophil/albumin ratio (NAR), and complete blood count-derived inflammatory markers; neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), monocyte/lymphocyte ratio (MLR), red-cell distribution width (RDW), and mean platelet volume (MPV) between patients with acutely exacerbated and remitted schizophrenia and healthy controls.
Methods: Anonymous data of a total of 618 patients with schizophrenia (179 in remission, 439 with acute exacerbation) and 445 psychiatrically and medically healthy subjects admitted to outpatient units were included. One-way ANOVA with Tukey's HSD post-hoc test, Pearson's correlation test, receiver operating characteristic analysis, and binomial logistic regression analysis were performed.
Results: CAR, NAR, NLR, PLR, MLR, RDW, MPV values were found higher in patients with schizophrenia than in healthy subjects. Except for NAR (p=0.007), none of the markers differed between acute exacerbation and remission. As a cut-off value of CAR, 0.388 differentiated patients with schizophrenia from controls (sensitivity 81%, specificity 81%). CAR, NAR, and MPV significantly predicted the diagnosis of schizophrenia.
Conclusion: CAR and NAR are reliable biomarkers of inflammation and a combination of inflammatory markers including CAR and NAR could be used to reflect the increased inflammatory status in schizophrenia, regardless of relapse or remission.
Keywords: C-reactive protein-albumin ratio; Inflammation; Relapse; Remission; Schizophrenia; Trait markers.
Conflict of interest statement
The authors have no potential conflicts of interest to disclose.
Figures

Similar articles
-
Relation Between Unconjugated Bilirubin and Peripheral Biomarkers of Inflammation Derived From Complete Blood Counts in Patients With Acute Stage of Schizophrenia.Front Psychiatry. 2022 Apr 7;13:843985. doi: 10.3389/fpsyt.2022.843985. eCollection 2022. Front Psychiatry. 2022. PMID: 35463529 Free PMC article.
-
The C-Reactive Protein/Albumin Ratio and Complete Blood Count Parameters as Indicators of Disease Activity in Patients with Takayasu Arteritis.Med Sci Monit. 2019 Feb 22;25:1401-1409. doi: 10.12659/MSM.912495. Med Sci Monit. 2019. PMID: 30792377 Free PMC article.
-
Neutrophil/lymphocyte ratio, monocyte/lymphocyte ratio, and mean platelet volume as systemic inflammatory markers in different states of bipolar disorder.Nord J Psychiatry. 2019 Aug;73(6):372-379. doi: 10.1080/08039488.2019.1640789. Epub 2019 Jul 13. Nord J Psychiatry. 2019. PMID: 31304832
-
Mean platelet volume, red cell distribution width, platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios in patients with ankylosing spondylitis and their relationships with high-frequency hearing thresholds.Eur Arch Otorhinolaryngol. 2016 Nov;273(11):3663-3672. doi: 10.1007/s00405-016-3980-y. Epub 2016 Mar 31. Eur Arch Otorhinolaryngol. 2016. PMID: 27034281 Clinical Trial.
-
The Impact of Biomarkers on the Early Detection of Acute Mesenteric Ischemia.Biomedicines. 2023 Dec 29;12(1):85. doi: 10.3390/biomedicines12010085. Biomedicines. 2023. PMID: 38255192 Free PMC article. Review.
Cited by
-
Pre- and post-treatment evaluation of routine blood analysis in patients with attention deficit hyperactivity disorder and comparison with the healthy control group.Sci Rep. 2023 Sep 27;13(1):16233. doi: 10.1038/s41598-023-43553-5. Sci Rep. 2023. PMID: 37758832 Free PMC article.
-
Meta-analysis of peripheral mean platelet volume in patients with mental disorders: Comparisons in depression, anxiety, bipolar disorder, and schizophrenia.Brain Behav. 2023 Nov;13(11):e3240. doi: 10.1002/brb3.3240. Epub 2023 Aug 29. Brain Behav. 2023. PMID: 37644555 Free PMC article. Review.
-
Platelet Parameters in First-Episode Patients with Schizophrenia and Bipolar Disorder.Psychiatry Clin Psychopharmacol. 2021 Sep 1;31(3):339-343. doi: 10.5152/pcp.2021.21695. eCollection 2021 Sep. Psychiatry Clin Psychopharmacol. 2021. PMID: 38765952 Free PMC article.
-
Mean platelet volume, platelet count, and neutrophil/lymphocyte ratio in drug-naïve patients with schizophrenia: a cross-sectional study.Front Psychiatry. 2023 May 9;14:1150235. doi: 10.3389/fpsyt.2023.1150235. eCollection 2023. Front Psychiatry. 2023. PMID: 37229382 Free PMC article.
-
Early Change in Platelet Count and MPV Levels of Patients Who Received Hemodialysis for the First Time: Mogadishu Somalia Experience.Int J Clin Pract. 2022 Jun 30;2022:1503227. doi: 10.1155/2022/1503227. eCollection 2022. Int J Clin Pract. 2022. PMID: 35832803 Free PMC article.
References
-
- Strous RD, Shoenfeld Y. Schizophrenia, autoimmunity and immune system dysregulation: A comprehensive model updated and revisited. J Autoimmun. 2006;27:71–80. - PubMed
-
- Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, Kouassi E. Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry. 2008;63:801–808. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials